Notification of change in auditor Mediclinic International plc (the “Company”) (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 4 March 2016 NOTIFICATION OF CHANGE IN AUDITOR Further to the announcement of 22 February 2016 regarding the change in the Company’s auditor, the Company hereby advises that KPMG LLP, the Company’s previous auditors, ceased to hold office on 19 February 2016 and, as required in terms of section 519(3) of the UK Companies Act 2006, have deposited a statement with the Company of the circumstances connected with them ceasing to hold office as auditors of the Company. In accordance with the requirements of section 520(2) of the UK Companies Act 2006, a copy of the statement received from KPMG LLP has today been sent to all shareholders together with an explanatory letter from the Company’s Chief Executive Officer, Danie Meintjes. In compliance with UKLA Listing Rule 9.6.1 the Company announces that the following documents have been submitted electronically to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM: - letter from KPMG LLP including a statement of circumstances connected with ceasing to hold office as auditors; and - Chief Executive Officer's explanatory letter. The documents will also be available shortly on the Investor Relations section of the Company’s website at www.mediclinic.com. Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom Website: www.mediclinic.com JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Limited For further information, please contact: Company Secretary Victoria Dalby +44 (0)207 954 9528 Capita Company Secretarial Services Limited Date: 04/03/2016 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.